The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report
Abstract
Purpose: To assess the effects of patient-controlled methylphenidate for cancer-related fatigue. Patients and Methods: In this prospective open study, 31 patients with advanced cancer and fatigue who scored ≥ 4 on a scale of 0 to 10 received methylphenidate 5 mg by mouth every 2 hours as needed for 7 days (maximum, 20 mg/d). Multiple symptoms were assessed daily; the primary end point, fatigue, was measured using the 0 to 10 scale, and the Functional Assessment for Chronic Illness Therapy–Fatigue (FACIT-F) was performed at baseline, day 7, and day 28. Results: The following mean (± standard deviation) scores for 30 assessable patients improved significantly between baseline and day 7: fatigue (0 to 10 scale), 7.2 ± 1.6 v 3.0 ± 1.9 (P < .001); overall well-being (0 to 10 scale), 4.5 ± 2.2 v 2.8 ± 2.1 (P < .001); fatigue (FACIT-F) subscore, 17.5 ± 11.3 v 34.7 ± 10.0 (P < .001); functional well-being, 14.4 ± 5.9 v 18.3 ± 6.6 (P < .001); and physical well-being, 13.5 ± 6.4 v 21.4 ± 5.0 (P < .001). Anxiety, appetite, pain, nausea, depression, and drowsiness all improved significantly (P < .05). All patients took afternoon or evening doses, and 28 patients (93%) took three or more doses daily. All patients chose to continue taking methylphenidate after 7 days of treatment. No serious side effects were reported. Conclusion: These preliminary results suggest that patient-controlled methylphenidate administration rapidly improved fatigue and other symptoms. Randomized controlled trials are justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study
Sugawara, Y., Akechi, T., Shima, Y., Okuyama, T., Akizuki, N., Nakano, T., & Uchitomi, Y. (2002) · Palliative Medicine · doi:10.1191/0269216302pm547xx · Cited by 64
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Self-citationBehavioral Symptoms in Patients With Breast Cancer and Survivors
Bower, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3248 · Cited by 483
Fatigue and cancer: causes, prevalence and treatment approaches
Wagner, L. I., & Cella, D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602012 · Cited by 364
Yennurajalingam, S., Frisbee-Hume, S., Palmer, J. L., Delgado-Guay, M. O., Bull, J., Phan, A. T., Tannir, N. M., Litton, J. K., Reddy, A., Hui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.4661 · Cited by 348
Self-citation
Metadata
- Authors
- Bruera, E., Driver, L., Barnes, E. A., Willey, J., Shen, L., Palmer, J. L., & Escalante, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-12-01
- Volume
- 21
- Issue
- 23
- Pages
- 4439-4443
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105028848
- Cited by
- 206
- References
- 2
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report. https://app.cochat.ai/papers/10.1200/jco.2003.06.156
- The paper
- Bruera, E., Driver, L., Barnes, E. A., Willey, J., Shen, L., Palmer, J. L., & Escalante, C. (2003). Patient-Controlled Methylphenidate for the Management of Fatigue in Patients With Advanced Cancer: A Preliminary Report. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2003.06.156
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.